April 24 - Day One
Location: Room 3102/3103
- Rosie Bernard - Senior Director, EBD Group
- Lee Chuan Teck - Chairman, Enterprise Singapore
Location: Room 3103/ 3104
As well as a growing hotspot for clinical trials, Asia Pacific holds the world’s second and third largest pharmaceutical markets with China and Japan leading the charge. The distinguished opening keynote panel will consist of influential pharma dealmakers leading the path to development, funding, and partnerships in the burgeoning Asian market.
- Helen Chen - Global Sector Co-Head, Healthcare and Life Sciences Greater China Managing Partner, L.E.K. Consulting
- Ya-Ting Lei - Director of Business Development & Licensing, Merck Group
- Geoff Quinn - Senior Director, Pfizer
- Jenny Yang - Senior Director, Global Search & Evaluation, Novo Nordisk
- Koji Yashiro - Director at Pacific BD&L, MSD
Location: Room 3103/ 3104
What assets are driving investments and partnerships? With the rise of antibody drug conjugates (ADC’s) in cancer drug development, what do investment and innovation look like in the Asian market in the next 10 years? Experts will share their insights on emerging areas of innovation, what deals to watch for, and how this impacts the future of development.
- David Chen - Managing Director, BFC Group
- Guy Heathers - CBO, Albatroz Therapeutics
- Shyam Masrani - Principal, Medicxi
- Damian O'Connell - CEO, Experimental Drug Development Centre
- Arthur Pappas - CEO & Managing General Partner, Pappas Capital
Location: Room 3103/ 3104
Hear pharma’s perspectives on outbound licensing deals, acquisitions, and collaborations, and strategies on how to get a deal done.
- Jennifer Raab - Partner, Cooley
- David Chen - Managing Director, BFC Group
- Lila Hope - Partner, Cooley
- Birgit Reitmaier - Head of BD Asia Pacific, Merck
- Matthew Sheroff - Head of New Business Development, Janssen Asia Pacific
Location: Room 3103/ 3104
Discussing key trends and considerations for dealing with investors and securing financing for life sciences companies, from private financing to capital markets transactions.
- Yiming Liu - Partner, Cooley
- Joe Gao - CFO, Singleron Biotechnologies
- Xiao Le - CFO, MegaRobo
- Fong Ming Koh - Principal, LYFE Capital
- Wenzhi Tian - Founder and CEO, ImmuneOnco
- Michael Yu - Partner, Cooley
Location: Room 3103/ 3104
- Brian Yang - Managing Editor, Citeline
- Anand Gautam - Founder, G2OME CONSULTING PTY LTD